247 related articles for article (PubMed ID: 16118343)
1. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring.
Luton D; Le Gac I; Vuillard E; Castanet M; Guibourdenche J; Noel M; Toubert ME; Léger J; Boissinot C; Schlageter MH; Garel C; Tébeka B; Oury JF; Czernichow P; Polak M
J Clin Endocrinol Metab; 2005 Nov; 90(11):6093-8. PubMed ID: 16118343
[TBL] [Abstract][Full Text] [Related]
2. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol.
Nachum Z; Rakover Y; Weiner E; Shalev E
Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156
[TBL] [Abstract][Full Text] [Related]
3. Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy.
Cohen O; Pinhas-Hamiel O; Sivan E; Dolitski M; Lipitz S; Achiron R
Prenat Diagn; 2003 Sep; 23(9):740-2. PubMed ID: 12975785
[TBL] [Abstract][Full Text] [Related]
4. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy.
Momotani N; Hisaoka T; Noh J; Ishikawa N; Ito K
J Clin Endocrinol Metab; 1992 Sep; 75(3):738-44. PubMed ID: 1517362
[TBL] [Abstract][Full Text] [Related]
5. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status.
Momotani N; Noh J; Oyanagi H; Ishikawa N; Ito K
N Engl J Med; 1986 Jul; 315(1):24-8. PubMed ID: 2423874
[TBL] [Abstract][Full Text] [Related]
6. Fetal and neonatal thyroid function in relation to maternal Graves' disease.
Polak M; Le Gac I; Vuillard E; Guibourdenche J; Leger J; Toubert ME; Madec AM; Oury JF; Czernichow P; Luton D
Best Pract Res Clin Endocrinol Metab; 2004 Jun; 18(2):289-302. PubMed ID: 15157841
[TBL] [Abstract][Full Text] [Related]
7. Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine.
Hoermann R; Quadbeck B; Roggenbuck U; Szabolcs I; Pfeilschifter J; Meng W; Reschke K; Hackenberg K; Dettmann J; Prehn B; Hirche H; Mann K;
Thyroid; 2002 Dec; 12(12):1119-28. PubMed ID: 12593726
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
Brokken LJ; Wiersinga WM; Prummel MF
J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276
[TBL] [Abstract][Full Text] [Related]
9. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
11. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy.
Ueta Y; Fukui H; Murakami H; Yamanouchi Y; Yamamoto R; Murao A; Santou Y; Taniguchi S; Mitani Y; Shigemasa C
Thyroid; 1999 Feb; 9(2):179-82. PubMed ID: 10090319
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves' disease patients: a sequential study before, during and after pregnancy.
González-Jiménez A; Fernández-Soto ML; Escobar-Jiménez F; Glinoer D; Navarrete L
Thyroidology; 1993 Apr; 5(1):13-20. PubMed ID: 7508738
[TBL] [Abstract][Full Text] [Related]
14. Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: characteristics of epitopes for thyrotropin receptor antibodies.
Chung HK; Kim WB; Park DJ; Kohn LD; Tahara K; Cho BY
Thyroid; 1999 Apr; 9(4):393-9. PubMed ID: 10319947
[TBL] [Abstract][Full Text] [Related]
15. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease.
Matsuura N; Harada S; Ohyama Y; Shibayama K; Fukushi M; Ishikawa N; Yuri K; Nakanishi M; Yokota Y; Kazahari K; Oguchi H
Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225
[TBL] [Abstract][Full Text] [Related]
16. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil.
Momotani N; Yamashita R; Makino F; Noh JY; Ishikawa N; Ito K
Clin Endocrinol (Oxf); 2000 Aug; 53(2):177-81. PubMed ID: 10931098
[TBL] [Abstract][Full Text] [Related]
17. [Maternal and cord blood thyroid hormones in Graves' disease and fetal states].
Koike S; Aoyama A; Yamaguchi N; Natori Y; Suzuki T; Itou M; Kusakabe K; Demura R
Rinsho Byori; 1993 Jun; 41(6):666-72. PubMed ID: 7689666
[TBL] [Abstract][Full Text] [Related]
18. Recurrent fetal thyrotoxicosis in a woman with Graves' disease: case report.
Ting MK; Hsu BR; Huang YY; Lin JD; Chen TC
Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):492-7. PubMed ID: 10584424
[TBL] [Abstract][Full Text] [Related]
19. [Pregnancy and the thyroid gland].
Lieutaud H
Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
